COMP <GO>
NUS vs CAH // EV/EBITDA & P/E VALUATION
Nu Skin Enterprises Inc. (NYSE) VS. Cardinal Health Inc. (NYSE) • 15-METRIC TALLY: NUS 6
— CAH 5
■ METRIC PARITY
LAST: $4.65 (-0.85%) • MKT CAP: $228.3M
valuation
—
LAST: $250.48 (-0.24%) • MKT CAP: $58.14B
valuation
24.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NUS VS. CAH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NUS | CAH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 69.40% | 3.70% | +65.70 | NUS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.70% | 29.70% | -23.00 | CAH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 24.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 20.15% | 3.18% | +16.97 | NUS | /fcf-yield <GO> |
| Operating Margin | 4.40% | 1.00% | +3.40 | NUS | /operating-margins <GO> |
| Net Profit Margin | 10.80% | 0.70% | +10.10 | NUS | /net-margins <GO> |
| Revenue Growth (YoY) | -14.30% | -1.90% | -12.40 | CAH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.18% | 0.85% | +4.33 | NUS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.54 | 5.16 | -1.62 | CAH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | NUS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.2 | 59.1 | -13.90 | CAH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.90 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 34.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $228.3M | $58.14B | -$57.91B | CAH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NUS REV | CAH REV | NUS GROSS % | CAH GROSS % | NUS FCF | CAH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.49B | $222.58B | 69.4% | 3.7% | $46.0M | $1.85B |
| FY 2024 | $1.73B | $226.83B | 68.2% | 3.3% | $70.2M | $3.25B |
| FY 2023 | $1.97B | $204.98B | — | — | $118.6M | -$6.38B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NUS // BETA —
CAH // BETA 0.90